The Problem

Trade disputes between Canada and the U.S. continue to pose a risk to our supply of medicines. If tariffs are added to medicines or the materials used to make them, it could harm patients, the healthcare system, and Canada’s life sciences sector.

The Problem

Trade disputes between Canada and the U.S. continue to pose a risk to our supply of medicines. If tariffs are added to medicines or the materials used to make them, it could harm patients, the healthcare system, and Canada’s life sciences sector.

By signing up, you agree to receive periodic emails from Medicine Matters Canada containing news, updates, and ways to get involved. Medicine Matters Canada is an initiative of Innovative Medicines Canada (“IMC”). These emails may be sent on IMC’s behalf by our service provider. You can unsubscribe at any time. Contact: Innovative Medicines Canada | 310-99 rue Bank St. Ottawa, ON K1P 6B9 | info@imc-mnc.ca